Graf Akcie AVNS (Avanos Medical Inc). Diskuze k akciím AVNS. Aktuální informace AVNS.

Základní informace o společnosti Avanos Medical Inc (Akcie AVNS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.52B
Hodnota podniku (EV) 1.61B
Tržby 737.8M
EBITDA 53.6M
Zisk 2.4M
Růst v tržbách Q/Q 13.87 %
Růst v tržbách Y/Y 4.61 %
P/E (Cena vůči ziskům) 817.00
Forward P/E N/A
EV/Sales 2.18
EV/EBITDA 29.94
EV/EBIT N/A
PEG 1.66
Price/Sales 2.07
P/FCF N/A
Price/Book 1.21
Účetní hodnota na akcii 26.95
Hotovost na akcii 2.39
FCF vůči ceně -0.35 %
Počet zaměstnanců 5,300
Tržba na zaměstnance 139.208k
Profit margin -3.81 %
Operating margin 1.75 %
Gross margin 52.22 %
EBIT margin -8.72 %
EBITDA margin 7.26 %
EPS - Zisk na akcii 0.04
EPS - Kvartální růst 61.54 %
EPS - Očekávaný růst příští rok 47.62 %
Return on assets 0.14 %
Return on equity 0.19 %
ROIC -2.59 %
ROCE -4.22 %
Dluhy/Equity 0.33
Čistý dluh/EBITDA 10.17
Current ratio 2.80
Quick Ratio 1.79
Volatilita 2.47
Beta 1.07
RSI 56.28
Cílová cena analytiků 44
Známka akcie (dle analytiků) 2.43
Insider ownership 1.07 %
Institutional ownership 93.81 %
Počet akcií 48.123M
Procento shortovaných akcií 2.88 %
Short ratio 1.47 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie AVNS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$714.8$697.6$652.3$611.6$566.2$509
Cost Of Goods Sold$341.5$295.4$261.4$274.7$269$251.2
Gross Profit$373.3$402.2$390.9$336.9$297.2$257.8
Research And Development Expenses$34.9$37.7$41.8$38.2$38.4$27.6
SG&A Expenses$332.6$399.1$340.4$321.7$346.2$349.7
Other Operating Income Or Expenses$-51.9$-21.1$-8.2$-20.1$-19.7$-16.2
Operating Expenses$760.9$753.3$651.8$654.7$673.3$644.7
Operating Income$-46.1$-55.7$0.5$-43.1$-107.1$-135.7
Total Non-Operating Income/Expense$-14.4$-8.3$-18.6$-29.1$-32.1$-32.8
Pre-Tax Income$-60.5$-64$-18.1$-72.2$-139.2$-168.5
Income Taxes$-33.3$-18.1$-9.6$-40.1$-55.9$-67.3
Income After Taxes$-27.2$-45.9$-8.5$-32.1$-83.3$-101.2
Other Income------
Income From Continuous Operations$-27.2$-45.9$-8.5$-32.1$-83.3$-101.2
Income From Discontinued Operations--$66$111.4$123.1$-325.1
Net Income$-27.2$-45.9$57.5$79.3$39.8$-426.3
EBITDA$-3.2$-18.8$34$16.4$-41.9$403.7
EBIT$-46.1$-55.7$0.5$-43.1$-107.1$-135.7
Basic Shares Outstanding484847474747
Shares Outstanding484847474747
Basic EPS$-0.57$-0.96$1.22$1.69$0.85$-9.15
EPS - Earnings Per Share$-0.57$-0.96$1.22$1.69$0.85$-9.15
# 2020 2019 2018 2017 2016 2015
Current Ratio2.80942.53412.72.97771.82952.1447
Long-term Debt / Capital0.12530.16390.16030.30810.34430.3539
Debt/Equity Ratio0.14330.19610.19090.47790.52520.5478
Gross Margin52.224457.654859.926455.08552.490350.6483
Operating Margin-6.4494-7.98450.0767-7.0471-18.9156-26.6601
EBIT Margin-6.4494-7.98450.0767-7.0471-18.9156-26.6601
EBITDA Margin-0.4477-2.6955.21232.6815-7.400279.3124
Pre-Tax Profit Margin-8.4639-9.1743-2.7748-11.8051-24.585-33.1041
Net Profit Margin-3.8053-6.57978.81512.9667.0293-83.7525
Asset Turnover0.42730.38760.35580.27850.27330.2545
Inventory Turnover Ratio2.02192.02472.15323.01543.33330.8285
Receiveable Turnover4.25734.25894.33423.01283.00372.2652
Days Sales In Receivables85.735285.703884.2136121.1494121.5162161.1306
ROE - Return On Equity-2.1647-3.6279-0.6553-2.6411-7.5556-9.5897
Return On Tangible Equity-9.1799-16.3929-2.4609-10.6362-48.4302-368.0016
ROA - Return On Assets-1.626-2.5506-0.4636-1.4618-4.0207-5.0595
ROI - Return On Investment-1.8935-3.0331-0.5502-1.8275-4.9539-6.1957
Book Value Per Share26.221926.505227.341725.903723.617222.6386
Operating Cash Flow Per Share1.51281.5196-6.1659-0.97031.9571-1.0862
Free Cash Flow Per Share2.15331.4968-6.2853-1.33542.7446-0.9091